Predicting esophageal cancer treatment response with AI and imaging
Part of Cancer, Digestive system clinical trials.
This trial uses artificial intelligence to analyze CT scans and predict how well esophageal cancer responds to chemotherapy combined with immunotherapy before surgery. The goal is to help doctors personalize treatment for better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with esophageal cancer (confirmed by biopsy).
- Your doctor recommended chemoimmunotherapy before surgery.
- You received chemoimmunotherapy before surgery.
- You have CT scans taken both before and after your neoadjuvant treatment.
- You did not refuse surgery if your surgeon said it was possible.
- You do not have another type of cancer besides esophageal cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a combination of imaging and clinical data to see if a computer model can predict how well your treatment will work. It aims to help doctors better understand your cancer risk and choose the best treatment plan for you.
This trial tests whether an artificial intelligence (AI) model can accurately predict if esophageal cancer will completely disappear after chemotherapy combined with immunotherapy before surgery. If successful, it could help doctors decide the best treatment plan for patients.
This trial uses artificial intelligence (AI) to help plan personalized treatment for esophageal cancer by combining images and tissue samples. It aims to improve care by guiding doctors to choose the best therapy for each person.
This trial uses artificial intelligence to create a digital twin of your cancer and simulate how it might respond to treatment. It aims to personalize your care and improve outcomes for people with locally advanced esophageal cancer.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
This trial uses artificial intelligence to analyze CT scans, blood, and tumor tissue to predict how well your cancer will respond to chemotherapy and immunotherapy before surgery. It aims to personalize treatment for locally advanced stomach or gastroesophageal junction cancer.
Hear when a new Esophagus Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.